Comorbid Conditions And Gout

Content

• Request Your Goutful Booklet
• Gout Raises Risk Of Heart Failure In Older Adults
• Kidney Stones
• New Data Demonstrates Link Between Gout And Cardiovascular Disease
• Find A Gout Specialist
• Health & Wellness

This included symptom reporting, heart imaging and exercise testing to determine aerobic capacity and endurance. The researchers concluded that older patients with gout are at risk for incident HF, which was consistent across sex- and race-related analyses. The baseline characteristics of cases and controls are presented in Table 1. Case patients were older (mean age, 78.7 years) and had a higher burden of comorbidities based on the modified Charlson index, particularly a higher prevalence of renal failure and prior myocardial infarction.

Request Your Goutful Booklet

Epidemiological, experimental and clinical data show that patients with hyperuricaemia SUA are at increased risk of cardiac, renal and vascular damage and CV events. There is now some evidence to suggest that urate-lowering treatment may reduce CV risk in this group and, thus, may represent a new strategy in risk reduction. Previous research has demonstrated that gout is associated with coronary heart disease and stroke, and the conditions also share many risk factors such as obesity, hypertension, and diabetes -- which also have been linked with heart failure. Research published in 2019 in Arthritis & Rheumatology also found that people with sleep apnea have an increased risk of gout, which is highest in the two years following diagnosis of the sleep disorder. Like gout, sleep apnea also raises risk for obesity, diabetes, high blood pressure, heart attack, and stroke, and researchers think the two disorders share common mechanisms.

From a total of 502 citations we removed 91 duplicate abstracts. We excluded 358 studies at the abstract level and selected 53 for full-text review; of these we excluded 28. Interrater agreement between reviewers on inclusion versus exclusion of studies was 100%. From the clinicaltrials.gov register, we retrieved additional cardiovascular events data for 5 of the 25 published studies [25, 38–41]. Among the 25 included studies, 10 reported MACE and 15 reported no CV events during the study follow-up.

Gout Raises Risk Of Heart Failure In Older Adults

And if they have modifiable risk factors -- like high cholesterol, high blood pressure or excess pounds -- it will be particularly important to get them under control, noted Krishnan, an assistant professor at Stanford University School of Medicine. A high proportion of patients stopped participating in the trial. In those who stopped taking febuxostat, the elevated risk of death decreased.

Also, patients with hyperuricemia could be symptomatic (i.e., gout) or asymptomatic. However, it is likely that the conclusions from studies about patients with hyperuricemia are also valid in patients with gout. Only a few studies have compared the efficacy and safety of uric acid lowering monotherapy, and solely one study looked at combination therapy of two uric acid lowering therapeutics. The combination of lesinurad and febuxostat was well tolerated, and the target serum uric acid level was achieved in all patients.

Most of the known genes play a role in transporting urate, which is a byproduct of normal biochemical processes. Many gout-associated genes play a role in releasing urate into the urine if levels are too high or reabsorbing it back into the bloodstream if more is needed in the body. Other associated genes are involved in transporting or breaking down sugars or transporting other small molecules. Of all the genes that have been studied, two genes, SLC2A9 and ABCG2, seem to have the greatest influence on urate levels. There was no statistical difference in age, gender, race, or BMI among patients who developed acute gout compared with those who did not develop acute gout while receiving IV bumetanide . There was an observed non-significant trend towards developing acute gout flares in younger patients.

Kidney Stones

This review starts with a clinical overview on the epidemiology, pathogenesis, clinical presentation, risk factors, diagnosis, treatment, and prognosis of gout. Hereafter, the review discusses the association between gout and cardiovascular diseases. In our retrospective cohort study, the annualized frequency of acute gout for patients receiving IV bumetanide for AHFE was found to be 7.17%. This frequency is on par with those documented in the literature . However, our study only evaluated gout flares in the setting of bumetanide use, so the inclusion of other loop diuretics such as furosemide would likely yield an frequency of acute gout higher than those previously reported.

Nonetheless, despite our efforts, some patients may have been misclassified according to gout status, which could have biased our effect estimates for remote gout and may have led to some residual confounding. Second, despite adjustments in our models for many important confounders such as renal failure, myocardial infarction, history of gout, daily diuretic dose, and comorbidities , some degree of confounding may still modify our estimates. We could not adjust for obesity, alcohol use, or socioeconomic status since these variables were not available. We also could not adjust our models for ejection fraction because this covariate was not available.

Conversely, population-based increases in serum uric acid, mediated by the use of thiazide and other diuretic agents, may have a detrimental effect on the burden of gout in the US population. Furthermore, future BP management guidelines should consider screening for hyperuricemia and gout in candidates with a thiazide indication, as well as discuss alternative medications with fewer serum urate-related effects . In addition to its disease manifestations in joints, gout appears to be associated with an increased risk of cardiovascular disease 2,5,6,7,8. When an association of gout and increased risk of CVD is proven, then a right and timely diagnosis and treatment will become more mandatory. Several studies showed a high prevalence of CVD in patients with gout, raising the question of whether gout is a risk factor for CVD9,10,11,12. However, these studies were based on the clinical diagnosis of gout, although the gold standard for diagnosing gout is the identification of MSU crystals in joint fluid by polarization microscopy13.

Using the latest technologies available, many of which we helped develop, we can accurately diagnose and treat your gout and the painful symptoms that accompany gout attacks. The big toe joint will swell, turn red, feel warm, and even the slightest touch can be agonizing. Fortunately, most gout attacks are sporadic and relatively infrequent. The most commonly reported adverse reactions with colchicine are gastrointestinal symptoms, including diarrhea, nausea, vomiting, and abdominal pain. Race, age, income, and insurance status are all factors in the distance a stroke patient must travel to receive certified care.

This molecule is a urate-anion exchange transporter, expression of which had been described only in the renal tubular epithelium. The presence of URAT-1 in endothelial cells may allow for explanations of intracellular effects of urate in endothelial cells. Certain foods that contribute to cardiovascular disease also increase the risk of gout. Red meat, excessive alcohol and foods with high fructose content are bad for both.

What happens if you ignore gout?

"If you think you have gout, don't ignore the signs," Everakes says. "These crystals can also form in the kidneys and lead to kidney stones and, in some cases, can result in chronic kidney failure."

Febuxostat was developed in an effort to offer a safer alternative to the mainstay therapy of allopurinol, which can cause kidney problems and is associated with rare but severe allergic reactions in some – particularly African-American – gout patients. Yet the two drugs were comparable with respect to a combination of non-fatal heart attack, non-fatal stroke, urgent surgery to treat angina, and death due to cardiovascular causes. In conclusion, the paradigm of the causative association of hyperuricemia and cardiovascular diseases seems to have progressed from one of skepticism to one of increasing evidence of a true relationship.

Find A Gout Specialist

Our report adheres to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Aside from cutting down on fatty and sugary foods, the consumption of foods with heart-healthy compounds such as omega 3s and antioxidants can help protect the heart and increase longevity. Omega 3s can be found in fortified eggs and in fish; and fruits and vegetables are rich in antioxidants. HDL, also known as the ‘healthy cholesterol’ is found in sources such in nuts and olive oil. However, it’s important to keep in mind that HDL sources are often high in calories and you should limit consumption to a tablespoon of oil and a few nuts per serving.

Health & Wellness

The researchers also obtained claims data for a 5% random sample of Medicare beneficiaries from 2008 to 2015 for an additional analysis of rates of heart failure, myocardial infarction, stroke, and all-cause mortality in gout patients. Although it’s unclear why gout might increase the risk of cardiovascular disease, she said possible reasons include increased oxidative stress and inflammation. Patients who had gout at any point during the study had a twofold increased risk of heart failure death compared to people who never developed gout. The study published Friday in The Journal of the American Heart Association sought to clarify older research on the link between cardiovascular disease and gout, which occurs in people with high levels of uric acid in the blood. Some folks are really in the camp that LDL cholesterol and LDL lipoproteins are the driver of cardiovascular disease, other people are more nuanced that they are a piece of the puzzle.